계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Diadem
company
About
Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.
- 1 - 10
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- €7.50M
- Industries
- Therapeutics
- Founded date
- Jun 1, 2012
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€7.50M
Diadem has raised a total of
€7.50M
in funding over 2 rounds. Their latest funding was raised on
Mar 7, 2022 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 7, 2022 | Debt Financing | €7.50M | 1 |
European Investment Bank
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Diadem is funded by 1 investors.
European Investment Bank
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Investment Bank
|
Yes | Debt Financing |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
